Document:

Agreement between Hank Krey and the Company

 Exhibit 10.1 
 SEPARATION AGREEMENT AND 
 RELEASE OF ALL CLAIMS 
 This Separation Agreement and Release of all Claims (“Release”) is made and entered into by and between Hank Krey (“Employee”)
and Huttig Building Products, Inc., its affiliates, subsidiaries, related corporations, successors and assigns (the “Company”) as of this 28th day of April, 2006 (the “Effective Date”). In consideration of the following promises, the parties agree as follows: 
 1. Employee acknowledges that he will separate from employment with the Company effective as of the earlier of (a) March 30, 2007 or (b) such date as Employee commences full-time employment with another
employer (such date being hereafter referred to as the “Separation Date”). As of the Separation Date, Employee’s employment relationship with the Company will end. In connection with Employee’s separation, the Company and
Employee have agreed to settle all matters relating to Employee’s employment relationship with the Company and its termination. 
 2. Employee
voluntarily terminates and irrevocably resigns from the Company effective as of the Separation Date, which termination and resignation is hereby accepted by the Company. Employee’s personnel file will reflect his resignation as of the
Separation Date. As of March 30, 2006, Employee shall automatically and without taking any further actions be deemed to have resigned from all officer and director positions then held by him with the Company and all of its subsidiaries.
Notwithstanding the foregoing, Employee will continue as an employee of the Company until the Separation Date, although his active employment will end on March 30, 2006. He will be on paid leave from March 30, 2006 through the Separation
Date (the “Severance Period”). Employee shall promptly notify the Company in writing if he becomes employed on a full-time basis by another employer prior to March 30, 2007 which notification shall include the amount of
Employee’s new base salary with his new employer. 
 3. In consideration for the releases and covenants by Employee contained in this Release, the
Company shall, on the terms and conditions hereinafter set forth, provide to Employee: 
  

	 	(a)	During the Severance Period, the Company shall pay Employee 100% of Employee’s current base salary (his current base salary is $195,000.00 on an annualized basis). If Employee
becomes employed by another employer prior to March 30, 2007, at a base salary less than Employee’s current base salary, then the Company shall continue to pay to Employee severance payments equal to the difference between Employee’s
new base salary and Employee’s current base salary until March 30, 2007. Such amounts will be paid in accordance with the Company’s regular payroll practices, prorated for any partial payroll periods, and will be subject to all
withholding and deductions currently applicable to compensation received by an employee as an employee of the Company. 

  

	 	(b)	On or promptly following the expiration of the 7-day revocation period set for in paragraph 11 of this Release, the Company shall pay Employee the entire balance (as of
December 31, 2005 and after taking into account 2005 results) of his EVA Bank account under the Company’s EVA Incentive Compensation Plan, subject to all withholding and deductions currently applicable to compensation received by an
employee as an employee of the Company. 

	 	(c)	On or promptly following the expiration of the 7-day revocation period set forth in paragraph 11 of this Release, the Company shall pay Employee the value of Employee’s
accrued, but unused vacation pay for 2006, which is equal to two and one-half days of pay based on Employee’s current base salary, subject to all withholding and deductions currently applicable to compensation received by an employee as an
employee of the Company 

  

	 	(d)	During the Severance Period, Employee will not receive or accrue any paid time off, such as vacation days or holidays. 

  

	 	(e)	During the Severance Period, Employee will have the right to continue to participate in the Company’s benefit programs (as those programs may exist from time to time), provided
that Employee contributes the same amount for such benefit coverages as other similarly situated employees (which contributions will be withheld from the payments provided in paragraph (a) above), and provided that the Company continues such
coverage for active employees. Notwithstanding the foregoing, during the Severance Period, Employee shall not be entitled to any coverage under the Company’s short-term or long-term disability plans or under any Company sponsored life
insurance. 

  

	 	(f)	Employee shall have the right to continued use of the Company vehicle (provided that Employee maintains compliance with HB-102 the Company Vehicle Policy), laptop and cell phone
currently assigned to Employee until the earlier of (i) the Separation Date or (ii) the date Employee relocates from the St. Louis, Missouri area, at which time Employee’s right to use such property shall terminate and Employee shall
be responsible for returning such property to the Company. 

  

	 	(g)	Any stock options and restricted stock granted to Employee under the Company’s equity incentive plans that are not vested as of March 30, 2006 shall be forfeited. The
stock options granted to Employee under such equity compensation plans that are vested as of March 30, 2006 shall remain exercisable for ninety (90) days following the Separation Date. 

  

	 	(h)	A statement that the Company’s records shall reflect Employee’s resignation effective as of the Separation Date, although his active employment will end on March 30,
2006. 

  

	 	(i)	A reference letter in the form attached hereto as Exhibit A and a commitment that any Company officer or human resources employee responding to a request from a potential
employer for an employment reference regarding Employee shall not provide an oral or written reference that is inconsistent with the terms of the attached reference letter. 

 Employee acknowledges that the above payments and benefits are provided to Employee in consideration and recognition of past services rendered and in exchange for Employee’s promises and obligations herein.
Employee further acknowledges that such payments and benefit are made in lieu of any and all payments or benefits that might otherwise be available to Employee arising out of his employment with the Company (excluding Employee’s non-forfeitable
balance, if any, in the Huttig Deferred Compensation Plan and Employee’s non-forfeitable rights to his accrued benefits, if any, under the Huttig 401(k) plan). 

 4. In consideration for the foregoing, Employee, Employee’s successors and assigns, and anyone claiming by or
through Employee (the “Employee Parties”) hereby irrevocably and unconditionally release and forever discharge the Company, its affiliates, subsidiaries, and related entities, and their respective owners, directors, officers, employees,
agents, successors and assigns (collectively the “Company Parties”) from and against any and all manner of actions, liability, causes of action, claims, demands, contracts, attorney’s fees, back pay, claims for personal injury,
discrimination, and/or mental anguish, claims for vacation pay, sick pay, or any other employee benefits, which any of the Employee Parties now may have or hold or at any time heretofore had or held, arising out of, existing by reason of, resulting
from, or based upon: Employee’s employment with Company, or the separation therefrom, and any employment practice, custom or policy of any of the Company Parties. 
 5. In consideration for the foregoing, the Company, its subsidiaries, their respective successors and assigns, and anyone claiming by or through the Company or any of its subsidiaries (collectively, the
“Releasing Company Parties”) hereby irrevocably and unconditionally release and forever discharge Employee and his successors and assigns (collectively, the “Released Employee Parties”), from and against any and all manner of
actions, liability, causes of action, claims, demands, contracts and attorney’s fees, which any of the Releasing Company Parties now may have or hold or at any time heretofore had or held, arising out of, existing by reason of, resulting from,
or based upon: Employee’s employment with Company, the performance of Employee’s duties or the failure of Employee to properly perform such duties, including, without limitation claims by any of the Releasing Company Parties against the
Released Employee Parties for indemnification or contribution for liability imposed by third party claims against the Releasing Company Parties. 
 6.
Employee shall be entitled to the payment and other consideration described above only if Employee signs this Release and delivers it to the Company within twenty-one (21) days of receipt of this Release and does not revoke this Release within
the revocation period described in paragraph 11 of this Release. Provided Employee signs and delivers this Release and does not thereafter revoke, the payment referred to in paragraph 1(a) above shall begin within ten (10) days after the
Company receives this signed Release. By signing this Release and delivering it to the Company on or before April 28, 2006, the parties acknowledge that Employee has timely signed and delivered this Release to the Company. 
 7. Employee acknowledges and agrees that the claims released and discharged hereby include, but are not limited to, claims that have been or could be asserted under:
(a) the Missouri Human Rights Act; (b) rights pursuant to Missouri Revised Statutes §287.780 and §290.140; (c) Title VII of the Civil Rights Act of 1964, as amended; (d) the National Labor Relations Act, as amended;
(e) the Fair Labor Standards Act, (f) the Employee Retirement Income Security Act of 1974, as amended; (g) Sections 1981 through 1988 of Title 42 of the United States Code, as amended; (h) the Civil Rights Act of 1866;
(i) the Civil Rights Act of 1871; (j) the Civil Rights Act of 1991; (k) the Americans with Disabilities Act of 1990; (l) the Rehabilitation Act of 1973; (m) the False Claims Act; (n) the Family and Medical Leave Act of
1993; (o) the Vietnam Era Veterans’ Readjustment Assistance Act of 1974, or any replacement acts; (p) the Immigration Reform Control Act, as amended; (q) the Occupational Safety and Health Act, as amended; (r) the
Workers’ Adjustment and Retraining Notification Act, as 

 amended; (s) the Older Worker Benefit Protection Act; (t) the Age Discrimination in Employment Act (u) the
Sarbanes-Oxley Act of 2002; (v) any other federal, state, municipal, or local law, constitution, statute, regulation, ordinance, executive order, decision or common law claim concerning employment, wages, hours of work, labor relations,
employment relations, fair employment practices, fair credit reporting, human rights, civil rights, service letters, occupational safety and health, discrimination in employment, or termination of employment including, without limitation, any claim
for wrongful termination, retaliation, or any other aspect of employment brought under Missouri statutory or common law; any one or more of causes of action, complaints, charges, or rights enforceable in any forum, whether a court or an
administrative agency; (w) any claim for vacation, sick or personal leave pay or payment pursuant to any practice, policy, handbook or manual of the Company (x) any and all claims for personal injury, emotional distress, libel, slander,
defamation, and other physical, economic, or emotional injury; (y) any public policy, contract (express, written or implied) except for this Release, tort, or common law; and (z) any allegation for any one or more of the Employee’s
indebtedness, claims, damages, causes of action, suits for legal or equitable relief, costs, attorneys’ fees, or liabilities of every nature and description and either direct or consequential. Employee does not hereby waive any rights or claims
that may arise after the date Employee signs this Release. In addition, Employee does not release any claims for medical treatment for worker’s compensation claims for injuries arising prior to execution of this Release or for any claim to
enforce the terms of this Release. 
 8. Employee agrees not to disparage the management, employees, business or products of the Company or any of the
Company Parties in any manner. The Company parties agree not to disparage the Employee Parties or Employee’s family in any manner. 
 9. Employee shall
hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company and its customers and suppliers, which shall have been obtained by Employee during Employee’s
employment with the Company and which shall not be or become public knowledge (other than by acts by Employee or Employee’s representatives in violation of this Agreement). Employee shall not, without the prior written consent of the Company,
communicate or divulge any such information, knowledge or data to anyone other than the Company and those designated by it. Following the expiration of the Severance Period, Employee shall continue to be obligated under this paragraph not to use or
to disclose secret or confidential information of the Company so long as it shall remain proprietary or protectable as confidential or trade secret information. 
 10. Employee agrees that, during the Severance Period, he will, without further compensation, be available to assist the Company as reasonably requested by the Company at mutually agreeable time(s) in the metropolitan St. Louis area
regarding activities pertaining to his prior responsibilities with the Company, not exceeding twenty-four (24) hours per calendar month, and do such other things as are reasonably requested by the Company to provide for an orderly transition of
his employment responsibilities. In addition, during the Severance Period, Employee agrees to assist the Company, and if necessary to testify through a deposition or at trial, with respect to matters related to periods during which he was employed
by the Company. The Company agrees that any services under this paragraph 10 will be requested in a manner that will not unreasonably interfere with Employee’s then current employment. Any services provided by Employee in excess of twenty-four
(24) hours per calendar month shall be compensated at the rate of $100.00 per hour, less required withholdings. 

 11. Employee acknowledges that Employee has been advised to seek an attorney for advice regarding the effect of this
Release prior to signing it. Employee also acknowledges that Employee was offered and was advised that Employee could take up to twenty-one (21) days to study this Release before signing it. Employee understands that Employee has the right to
revoke this Release for seven (7) days after signing by providing written notification to Darlene Schroeder, Vice President—Human Resources at 555 Maryville University Drive, Suite 200, St. Louis, Missouri, 63141. In the event that
Employee revokes this Release during such 7-day period, this Release shall be null and void in its entirety and all of the Company’s obligations hereunder shall cease immediately. 
 12. Employee agrees that his request for a service letter under Missouri Revised Statute Section 290-140 is hereby withdrawn. 
 13. Employee acknowledges that Employee has read the entire contents of this Release, understands all of its terms, and has executed it voluntarily with full knowledge
of its significance. Employee represents and warrants that no other consideration has been promised to Employee for executing this Release other than as described in paragraph 1 above, and that no attorney or counsel is entitled to any fees as a
result of this Release. 
  

							
	HANK KREY	 		 	HUTTIG BUILDING PRODUCTS, INC.
				
	 /s/ HANK KREY
	 		 	By:	 	 /s/ Darlene K. Schroeder

	Signature	 		 	Its:	 	Vice President, Human Resources
				
	Date: April 28, 2006	 		 	Date:	 	April 28, 2006Amendment, dated March 28, 2006 to Patent License of Displays

 Exhibit 10.18.1 
 March 17, 2006 
 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN
SEPARATELY FILED WITH THE COMMISSION. 
 2006 AMENDMENT No. 1 
 To the Patent License for Displays and Display Illumination 
 Dated
October 16, 2001 (the “Agreement”) 
 Background 
 Cambridge Display Technology, Limited, and Cambridge Display Technology, Inc. are either the licensing entity, controlling entity of such licensing
entity, or the affiliate and Subsidiary thereof, and as such are the owner, joint owner, or sub-licensor of the Patents subject to the above referenced Agreement (collectively referred to herein as “CDT” or “Licensor”) and

 E.I. du Pont de Nemours and Company (hereinafter referred to as “Licensee” of the above referenced Agreement) and Uniax Corp.,
now known as DuPont Displays, Inc., (a wholly owned Subsidiary of Licensee, collectively with Licensee referred to hereinafter as “DuPont”), executed the Agreement on October 16, 2001; 
 In the time that has passed since executing the Agreement, CDT and DuPont have continued to develop the technology relating to LEP Devices and Finished
Products; 
 CDT and DuPont have determined that certain aspects of the Agreement do not meet the current commercial conditions relating to
continued development of technology relating to LEP Devices and Finished Products; and 
 Consequently, CDT and DuPont have determined that
amendments to the Agreement would address certain of their respective concerns, and in exchange for the mutual promises and consideration as recited herein, CDT and DuPont hereby mutually agree to amend the Agreement as set forth below and in the
attached Exhibits hereto. 
 Amendments To The Agreement 
 It is agreed as follows: 
 This
2006 Amendment No. 1 shall be effective on date of the last signature of the parties signing this 2006 Amendment No. 1, (the “Effective Date of the 2006 Amendment No. 1”). All capitalized terms shall have the meaning set
forth in the Agreement unless otherwise amended below. 
 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 

	1.	Under Clause 1: Definitions and Interpretation. 

 Unless otherwise defined below, the definitions of the Agreement are incorporated by reference. 
 Under “Have-Made
Partner”, add the following words at the end of the existing definition: 
 —provided that such entity shall not be authorized to act as a
distributor and in particular shall not be authorized to market, supply, sell or offer to supply or sell such Covered LEP Devices or Covered Finished Products otherwise than directly to the Licensee (or CDT, depending upon the context) and/or
Member(s) of the Licensee’s Group (or CDT’s Group, depending upon the context).— 
 Under “LEP Device” add
the following words at the end of the existing definition: 
 —and shall include back lights for use in such electronic
display devices.— 
 Under “Licensee’s Group” add new Clause (c) as follows: 
 — (c) an entity to which Licensee directly or indirectly owns at least 50% of the voting securities on the date Licensee executes a sublicense
to such entity and provided that the Licensee exercises effective working control over such entity; and a single entity to be nominated in writing by Licensee which Licensee directly or indirectly owns at least 40% of the voting securities on the
date Licensee executes a sublicense to such entity. — 
 Under “More Favourable License” add the following phrase at
the end of definition prior to the last period (“.”) 
 — , as set forth in Clauses 2.10-2.12, as amended. — 

Under “Relevant Rate” Clauses a) and b) shall be replaced with the following language for Covered Cell and Covered Active Matrix
Module: 
 — a) Covered Cell “***” 
 If at any time DuPont reasonably considers that the manufacturing costs (in accordance with US GAAP) of a Covered Cell are greater than “***” of the total manufacturing cost of the Covered Active Matrix
Module, it shall notify CDT in writing providing such information as CDT may reasonably require to verify such manufacturing costs. In the absence of agreement, the actual manufacturing costs shall be determined by an expert who in the absence of
agreement shall be appointed by the President of the Institute of Chartered Accountants, who shall sign an appropriate confidentiality agreement with DuPont. Where the expert 
 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -2- 

 determines that the manufacturing costs are within “***” of the figure provided by Dupont, the
costs of the expert shall be paid for by CDT. Where the expert determines that the manufacturing costs are not within “***” of the figure provided by Dupont, the costs of the expert shall be paid for by DuPont. Upon the agreement of the
parties or the determination of the expert that the manufacturing costs of a Covered Cell are greater than “***” of the total manufacturing cost of the Covered Active Matrix Module the royalty for a Covered Cell shall be reduced to:

 {Manufacturing costs of a Covered Active Matrix Module divided by Manufacturing costs of a Covered Cell} multiplied by “***”

 Provided always that the royalty shall never be less than “***”, unless reduced pursuant to Licensee’s More Favourable
License rights. 
 b) A Covered Active Matrix Module — “***”— 
 Under “Relevant Technology” Under Clause (1)) delete the last “; and” located at the end of the paragraph and insert a
period (“.”) . Then, delete all of Clause (2)(b) . 
 Amend Schedule 2 to add additional patents, U.S. Patent Nos. 5,895,717
and 5,682,043. 
 Add New Definitions as follows: 
  

							
	 More Favourable Running
 Royalty
	 	Means a running royalty rate which is less than the running royalty rate applying to this Agreement (namely the Relevant Rate).
		
	More Favourable Minimum Royalty	 	Means a minimum royalty calculated on an annual basis which is less than the minimum royalty applying to this Agreement (namely the Minimum Royalty).
		
	Relevant Licence	 	Means any agreement between CDT and any Third Party:
			
		 	1.	 	granting such Third Party any license to any of the Patents (CDT’s Patents) for the exploitation of
				
		 		 	a.	 	any LEP Device; or
				
		 		 	b.	 	any other display device or device for display illumination which in either case incorporates light emitting polymer (including, but not limited to, LEP Material); and
			
		 	2.	 	which includes such devices where the pixels are driven by individual switching elements or a thin film transistor.

 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -3- 

					
	Comparable Licence	 	Means a Relevant Licence which includes the right to manufacture or sell products (regardless of whether such products are a Covered LEP Device) in at least one country selected from
the group consisting of any country that is a member of the European Union, Japan, China, South Korea and Taiwan.
		
	Cross Licence	 	Means a Relevant Licence (including a Comparable Licence) under which the Third Party grants back to CDT a license, with sub licensing rights, in respect of any Intellectual Property
belonging to or within the control of such Third Party, and wherein such Third Party Intellectual Property is a substantial portfolio. A substantial portfolio is determined in view of its actual commercial and technical significance to the practice
of polymer OLED active matrix devices

  

	2.	Under Clause 2: CDT License Grant 

 Amend Clause
2.1(b), line 2, change the word “two” to – four –. 
  

	3.	Under Clauses 2.10-2.15 

 Delete current Clause 2.10
– insert new Clauses 2.10-2.12 as set forth below: 
  

	2.10.	If CDT (or Member of CDT’s Group) enters into a Relevant Licence containing a More Favorable Running Royalty, it shall offer such More Favorable Running Royalty to the Licensee
(DuPont) on the terms set out below. 

  

	 	(a).	the More Favorable Running Royalty shall take effect from the day when the More Favorable Running Royalty is binding upon CDT (or Member of CDT’s Group) and the Third Party (if
necessary retrospectively); 

  

	 	(b).	the More Favorable Running Royalty offered under this Clause 2.10 shall be subject to the Licensee (DuPont) undertaking any additional or different terms and conditions as are
undertaken by the Third Party which are applicable to the More Favorable Running Royalty (the “Assumed Terms and Conditions”) to the extent such terms and conditions fall into the following categories: 

  

	 	i	fixed annual royalty (as opposed to minimum royalties or Minimum Royalty) obligations in addition to the More Favorable Running Royalty; and 

 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -4- 

	 	ii	sales volume(s) at which a different royalty rate prevails; 

  

	 	(c).	if the Relevant License is a Cross Licence which contains a More Favorable Running Royalty, then in discharge of its obligation under this Clause 2.10, CDT may in its absolute
discretion either: 

  

	 	i	grant Licensee (DuPont) a royalty-free license to such Intellectual Property rights owned or controlled by such Third Party (such licence being consistent with the scope of rights
granted to CDT under such Cross Licence); or 

  

	 	ii	give Licensee (DuPont) the More Favourable Running Royalty; and 

  

	 	(d).	Licensee (DuPont) may in its sole discretion either accept or decline the offer of a More Favorable Running Royalty as set forth above in this Clause 2.10. 

 

	2.11.	If CDT (or Member of CDT’s Group) enters into a Comparable Licence containing a More Favorable Minimum Royalty, it shall offer such More Favorable Minimum Royalty to the
Licensee (DuPont) on the terms set out below. 

  

	 	(a).	the More Favorable Minimum Royalty shall take effect on the day when the More Favorable Minimum Royalty is binding upon CDT (or Member of CDT’s Group) and the Third Party;

  

	 	(b).	the More Favorable Minimum Royalty offered under this Clause 2.11 shall be subject to the Licensee (DuPont) undertaking any additional or different terms and conditions as are
undertaken by the Third Party in respect of the More Favorable Minimum Royalty (the “Assumed Terms and Conditions”), to the extent such terms and conditions fall into the following categories: 

  

	 	i	annual payment obligations in addition to the More Favorable Running Royalty; and 

  

	 	ii	sales volume as which a different royalty rate prevails; 

  

	 	(c).	if the Comparable License is a Cross Licence which contains a More Favorable Minimum Royalty, then in discharge of its obligation under this Clause 2.10, CDT may in its absolute
discretion either: 

  

	 	i	grant Licensee (DuPont) a royalty-free license to such Intellectual Property rights owned or controlled by such Third Party (such licence being consistent with the scope of rights
granted to CDT under such Cross Licence); or 

 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -5- 

	 	ii	give Licensee (DuPont) the More Favourable Minimum Royalty; 

  

	 	(d).	Licensee (DuPont) may in its sole discretion either accept or decline the offer of a More Favorable Minimum Royalty as set forth above in this Clause 2.11. 

 

	2.12.	The Parties agree to the following process in respect of any issues arising concerning the applicability of Clause 2.10 and 2.12, herein: 

  

	 	(a).	If at any time, after the date of this 2006 Amendment to the Agreement, CDT enters into any agreement with any Third Party giving such Third Party the right to exploit any display
device or device for display illumination which in either case incorporates light emitting polymer (including, but not limited to LEP Material), then unless CDT is bound by a duty of confidentiality in relation to such Third Party-agreement, CDT
will notify Licensee (DuPont) within thirty (30) days of the execution of such Third Party-agreement and shall supply Licensee (DuPont) with a complete copy of thereof and a complete copy of other agreements with such respective Third
Party(ies) that may have been negotiated or executed around the same time as the Third Party-agreement and are linked thereto, including, but not limited, to any material supply agreements, services contracts, credits, loans, rebates, forgiveness of
loans, or side letters, with such Third Party; 

  

	 	(b).	Where CDT is under a duty of confidentiality in relation to such agreement referred to in Clause 2.12 (a) above, CDT shall within thirty (30) days of the execution of such
agreement with a Third Party notify Licensee (DuPont) that an agreement giving such Third Party the right to exploit any display device or device for display illumination which in either case incorporates light emitting polymer (including, but not
limited to LEP Material) has been entered into without disclosing either (1) the identity of the Third Party (unless this is otherwise disclosed by CDT’s in any required disclosures by any public securities exchange (e.g., NASDAQ) or any
government agency regulating corporate securities (e.g., the U.S. Security Exchange Commission) filings or (2) the terms of the Third Party-agreement(s) to Licensee (DuPont); 

  

	 	(c).	Within fourteen (14) days or as soon as reasonably practicable thereafter, Licensee (DuPont) shall supply CDT with the name, address and contact details of external counsel
(External Counsel) retained on behalf of Licensee (DuPont) for the purposes set out below; 

  

	 	(d).	As soon as reasonably practicable, no later than thirty (30) days following the supply by Licensee (DuPont) of the contact details of External Counsel (which shall be and
remain Licensee’s (DuPont’s) counsel), CDT shall supply a complete copy of the full set of agreements (including linked agreements) relating to the transaction(s) of the Third Party-agreement referred to in Clause 2.12 (a), above to
External Counsel PROVIDED that such External Counsel shall have executed a commercially reasonable confidentiality agreement which is reasonably satisfactory 

 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -6- 

 to CDT and which is not unreasonably burdensome to External Counsel, which shall, amongst other matters,
require the External Counsel to confine his communications to Licensee (DuPont) concerning the contents of the Third Party-agreement solely to a statement as to whether or not the Third Party-agreement under review is a Relevant Licence and if so,
whether the Third Party-agreement is a Comparable Licence and/or a Cross Licence, and in each case whether the Third Party-agreement contains a More Favorable Royalty and/or a More Favorable Minimum Royalty without giving reasons. If External
Counsel determines that the Third Party-agreement is a Relevant Licence, Cross Licence, or Comparable Licence, External Counsel may communicate the terms and conditions which Licencee (DuPont) will be asked by CDT to assume (namely, the Most
Favourable Running Royalty, Most Favourable Minimum Royalty, and/or any Assumed Terms and Conditions) as well as External Counsel’s opinion as to what any Assumed Terms and Conditions should be. 
 Any and all analyses of External Counsel pursuant to this Clause 2.12(d) and any and all communications between External Counsel and Licensee (DuPont)
shall be considered the attorney work product of Licensee’s (DuPont’s) attorney and/or otherwise protected from disclosure to either CDT, the arbitrator, or any other Third Party in view of Licensee’s (DuPont’s) attorney-client
privilege. 
 Nothing in this Clause 2.12(d) or this 2006 Amendment to the Agreement, shall limit or be construed to limit Licensee’s
(DuPont’s) ability to communicate information to the External Counsel or answer questions posed to Licensee (DuPont) by External Counsel so as to aid External Counsel in reaching its statement as to whether or not any Third Party-agreement
under review is a Relevant Licence, Comparable Licence, and/or Cross Licence, and in each case, whether the Third Party-agreement contains a More Favorable Royalty and/or a More Favorable Minimum Royalty and the Assumed Terms and Conditions;

  

	 	(e).	CDT shall reimburse Licensee (DuPont) of all of the reasonable fees and expenses of External Counsel retained by Licensee (DuPont) pursuant to Clause 2.12 (d) above up to a
maximum of “***” in respect of each Third Party-agreement so referred irrespective of the number of any additional agreements supplied with such Third Party-agreement pursuant to Clause 2.12 (d) above. 

 CDT shall remit such payment to Licensee (DuPont) within thirty (30) days of receipt of an invoice from DuPont. If payment is not received by
Licensee (DuPont) within thirty (30) days, Licensee (DuPont), in addition to any other remedies, may offset the amount of any un-paid Clause 2.12(e) invoices against any other fees or payments due to CDT by either Licensee (DuPont) or any of
its Subsidiaries. CDT may not audit such invoices beyond information relating to the hourly rate of the External Counsel and the total time spent on such Clause 2.12(d) review. Nothing in Clause 2.12 shall be deemed a waiver of Licensee’s
(DuPont’s) attorney-client privilege as to any communication with External Counsel or other counsel and nothing shall be construed to permit CDT, arbitrator, or any other Third Party to have access to any of attorney work product of External
Counsel (including all Clause 2.12(d) statements made to Licensee (DuPont) or other Licensee (DuPont) counsel); 
 *** CONFIDENTIAL MATERIAL REDACTED AND
SEPARATELY FILED WITH THE COMMISSION. 
  

 -7- 

	 	(f).	If at any time Licensee (DuPont) has reasonable grounds to believe that CDT has entered into a Relevant Licence having a More Favorable Running Royalty or a Comparable Licence
having a More Favorable Minimum Royalty, Licensee (DuPont) shall promptly notify CDT in writing of such belief stating the basis for such belief; 

  

	 	(g).	Upon receipt of the Clause 2.12(f) notice, the Parties agree to promptly enter into a good faith negotiations (to include the utilization of procedures for DuPont’s use of
External Counsel as set forth in Clause 2.12(c) – (e) above) to determine whether CDT has entered into a Relevant Licence that contains a More Favorable Running Royalty or a Comparable Licence that contains a More Favorable Minimum Royalty
and if so, any of the Assumed Terms and Conditions applicable; 

  

	 	(h).	Such negotiations pursuant to Clause 2.12 (g) shall take place for not more than ninety (90) days after receipt by CDT of the relevant Clause 2.12(f) notice(s);

  

	 	(i).	If no agreement is reached by the Parties within the ninety (90) days specified under Clause 2.12(h) above, either Party may refer the issue to senior management for review. If
so desired by either Party, the referring Party shall send written notice to the other Party requesting this Clause 2.12(i) senior management review, whereupon each Party shall appoint their own respective employee for the senior management review
(such employee being an employee other than the one previously handling the issue for such respective Party) to meet with the appointed employee of the other Party, respectively, and such appointed employees shall use reasonable endeavours to
resolve the dispute in good faith; 

  

	 	(j).	If no agreement is reached by the Parties under Clauses 2.12(i), above, within forty five (45) days after the notice requesting senior management review is sent by one Party to
the other Party, either Party may refer the remaining dispute to be resolved by arbitration in accordance with the rules of the American Arbitration Association (“AAA”) using one arbitrator agreed to by the Parties. The location for any
and all arbitration hearings shall be New York, New York or as otherwise agreed to by the Parties. If the Parties cannot agree on an arbitrator, the Parties agree to accept an arbitrator selected by the AAA. The Parties shall pay their own
respective costs and fees of any arbitration. The Parties shall share the costs and fees of the arbitrator equally. Unless other arrangements are agreed to by the Parties and the arbitrator, or as may required by the AAA rules, each Party shall pay
its share of the arbitration costs and fees within thirty (30) days of receipt of any invoices from the AAA, the arbitrator, or appropriate entity, as the case may be, respectively. The Parties shall use reasonable efforts to reach an arbitral
award no later than ninety (90) days after the selection/appointment of the arbitrator; 

 *** CONFIDENTIAL MATERIAL REDACTED AND
SEPARATELY FILED WITH THE COMMISSION. 
  

 -8- 

	 	(k).	Nothing in this Clause 2.12 shall oblige CDT to breach obligations of confidentiality owed to Third Parties or to seek waivers of such obligations PROVIDED that such CDT obligations
to Third Parties do not prohibit CDT from meeting its obligations to Licensee (DuPont) as agreed to in Clauses 2.12(a)-(n); 

  

	 	(l)	Notwithstanding any of the above procedures and time period obligations, any dispute relating to any of Licensee’s (DuPont’s) rights as set forth in these Clauses 2.10
-2.12, if not resolved by the Parties after one-hundred seventy five (175) days measured from the date of Clause 2.12(f) notice sent by Licensee (DuPont), Licensee (DuPont) may seek resolution of any remaining dispute via arbitration. Such
arbitration shall be in accordance with the rules of the AAA using one arbitrator agreed to by the Parties. The location for any and all arbitration hearings shall be New York, New York at a location designated by the arbitrator, or as otherwise
agreed to by the Parties. If the Parties cannot agree on an arbitrator, the Parties agree to accept an arbitrator selected by the AAA. The Parties shall pay their own respective costs and fees of any arbitration. The Parties shall share the costs
and fees of the arbitrator equally. Unless other arrangements are agreed to by the Parties and the arbitrator, or as may required by the AAA rules, each Party shall pay its share of the arbitration costs and fees within thirty (30) days of
receipt of any invoices from the AAA, the arbitrator, or appropriate entity, as the case may be, respectively. The Parties shall use reasonable efforts to reach an arbitral award no later than ninety (90) days after the selection/appointment of
the arbitrator; 

  

	 	(m)	Notwithstanding Clauses 2.12(j) and (l), any dispute between the External Counsel and CDT regarding the commercial reasonableness of or whether there are unreasonable burdens placed
on External Counsel pursuant to any confidentiality agreement proposed by CDT (as anticipated by Clause 2.12(d) above) or the completeness of the documents provided to External Counsel by CDT, may be referred to arbitration by Licensee (DuPont) no
sooner than sixty (60) days after External Counsel’s receipt of the first proposed confidentiality agreement from CDT. Such arbitration shall be in accordance with the rules of the AAA using one arbitrator agreed to by the Parties. The
location for any and all arbitration hearings shall be New York, New York at a location designated by the arbitrator, or as otherwise agreed to by the Parties. If the Parties cannot agree on an arbitrator, the Parties agree to accept an arbitrator
selected by the AAA. The Parties shall pay their own respective costs and fees of any arbitration. The Parties shall share the costs and fees of the arbitrator equally. Unless other arrangements are agreed to by the Parties and the arbitrator, or as
may required by the AAA rules, each Party shall pay its share of the arbitration costs and fees within thirty (30) days of receipt of any invoices from the AAA, the arbitrator, or appropriate entity, as the case may be, respectively. The
Parties shall use reasonable efforts to reach an arbitral award no later than ninety (90) days after the selection/appointment of the arbitrator; and 

  

	 	(n)	All arbitral awards shall be deemed final and each Party waives the right to appeal the arbitral award to the extent permitted by applicable laws, with the exception that any
manifest error or default of the arbitrator may be appealed by either Party to the appropriate court of competent jurisdiction. Each Party consents to the jurisdiction of the particular courts as appropriate for enforcement of the arbitral award.

 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -9- 

                     end of new Clause
2.12                     
 Renumber original Agreement Clauses 2.12 to 2.15, to become renumbered Clauses 2.13 to 2.16, respectively. 
  

	4.	Under Clause 4: Intellectual Property and Proceedings. 

 Under Clause 4.1, first paragraph, line 2, and insert after “Relevant Technology” the following phrase: 
 — , subject
to the requirements of Clause 4.1(c) below, — 
 Add new Clause 4.1 (c) as follows: 
 — (c) As a condition of the license granted under Clause 4, CDT, its Subsidiaries, and Members of CDT’s Group, hereby agree to be bound the
terms and conditions attached here to as Exhibit A. With respect to CDT’s rights under the Relevant Technology listed in Schedule 2 of the Agreement all terms and conditions of the Agreement, the 2006 Amendment No. 1, and its Exhibit A
shall govern CDT’s rights thereto. 
 To the extent any term or condition of the Agreement or the 2006 Amendment
No. 1 renders any term and condition of Exhibit A impossible to perform, the terms and conditions of Exhibit A shall govern, control, or otherwise determine CDT’s rights, privileges, obligations, and performance related to CDT’s and
Members of CDT’s Group’s exercise of the Clause 4 license granted under the DuPont / Uniax Reference 001 listed in Schedule 2 of the Agreement, and CDT and Members of CDT’s Group shall comply with the requirements and obligations as
set forth in Exhibit A. – 
 5. Notwithstanding any paragraph to the contrary in the Agreement, (i) *** as required by DDI’s agreements ***
and as required by the *** (including, but not limited to, to the *** and its accountant ability to inspect this Agreement, records relating thereto, etc.) or Licensee’s Group who are similarly bound to treat this as confidential, or
(ii) either Party may disclose, without the other Party’s consent, the Agreement and amendments thereto to any Third Party advisors, investors, acquirers or prospective investors or acquirers who are similarly bound to treat the Agreement
(and amendments thereto) as confidential under similar terms and conditions as provided by the Agreement. 
 *** CONFIDENTIAL MATERIAL REDACTED AND
SEPARATELY FILED WITH THE COMMISSION. 
  

 -10- 

 6. CDT reserves the right to terminate its sublicense to the Regents Patents without terminating its licensed rights to
the other patent and patent applications listed in Relevant Technology. 
 7. CDT hereby waives its entitlement to the accumulative sum of “***” in
respect of any payments due during the duration of the Agreement as may become due on or after January 1, 2006 under Clauses 3.1 - 3.14 of the Agreement, including, but not limited to, the running royalties due on Covered LEP Devices and the
Minimum Royalty calculated on October 16, 2006, (as may be due by any activities of DuPont, its Have Made Partners, DuPont Subsidiaries, or Members of Licensee’s Group); PROVIDED that such waiver shall cease to apply to any unused portion
of the “***” as of the effective date of any assignment pursuant to Clause 12.2 of the Agreement. 
 8. DuPont hereby provides *** pursuant to
original Clause *** of the Agreement (renumbered in view of this 2006 Amendment No. 1 as Clause ***), in relation to the arrangements that CDT has entered into with Sumitomo Chemical Company Limited for the formation of Sumation Company Limited
as described in CDT’s filings with the U.S. Securities and Exchange Commission in November 2005. DuPont explicitly ***. 
 *** CONFIDENTIAL MATERIAL
REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -11- 

 OTHER TERMS AND CONDITIONS OF THE 2006 AMENDMENT 
 Unless otherwise explicitly stated in this 2006 Amendment No. 1, terms and conditions of the 2006 Amendment No. 1 shall be applicable to
prospective activities of the Parties taken after the Effective Date of the 2006 Amendment No. 1. 
 IN WITNESS WHEREOF, the CDT and
DuPont have executed this 2006 Amendment No. 1 to the Agreement, in duplicate originals, and by their respective duly authorized officers, as signed below. 
 For: 
  

							
	CAMBRIDGE DISPLAY TECHNOLOGY LTD.	  	 	 	CAMBRIDGE DISPLAYS TECHNOLOGY, INC.
				
	 	 	 /s/ S. Chandler
	  	 	 	 /s/ David Fyfe

	 Name:
	 	 Stephen Chandler
	  		 	 David Fyfe

	 Title:
	 	 Vice President, Legal and IP
	  		 	 Chief Executive Officer

			
	 Date: 27/MAR/06
	  		 	 3/27/06

			
	 Witness:
	  		 	
				
		 	 /s/ A. Fields
	  		 	 /s/ Thomas M. Clayton Witness

	 Name:
	 	 Andrew Fields
	  		 	 Thomas M. Clayton

			
	 E.I. DU PONT DE NEMOURS AND COMPANY and
 DUPONT DISPLAYS, INC.
	  		 	
				
		 	 /s/ Craig B. Naylor
	  		 	
	 Name:
	 	 Craig Naylor
	  		 	
	 Title:
	 	Group Vice President, Electronic and Communications Technologies and Agent for DuPont Displays, Inc.	  		 	
			
	 Date: 3/22/06
	  		 	
				
	 Witness:
	 		  		 	
				
		 	 /s/ Elizabeth L Ciccone 3-22-06
	  		 	
	 Name:
	 	 Elizabeth L. Ciccone
	  		 	

 *** CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION. 
  

 -12-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}]]